Show Summary Details
Page of

Treatment Resistance in Personality Disorders 

Treatment Resistance in Personality Disorders
Treatment Resistance in Personality Disorders

Glen O. Gabbard

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 November 2018

Personality disorders frequently require longer and more complicated treatment plans than Axis I disorders. Nevertheless, the prognosis is often quite favorable. Comorbidity is a frequent issue in the treatment, and misdiagnosis also tends to delay specific treatments tailored to the personality disorder. SSRIs may be useful in treating comorbid depression, but recent research suggests that they may make significant changes in the personality features as well. Psychotherapeutic efforts may be hampered by a poor fit between the type of therapy and the characteristics of the patient, insufficient attention to the therapeutic alliance, family issues, countertransference issues in the therapist, and overestimation of the patient’s capacity to use insight-oriented therapy.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.